Our in silico modelling and in vitro testing workflows are anchored to key events of Adverse Outcome Pathways (AOPs)
We can apply a variety of algorithms and machine learning techniques to SaferSkin™ datasets supporting the building of reference and customised models
For skin sensitization we have reproduced the leading defined approaches developed and used at industry leaders such as P&G, BASF, Givaudan and Shiseido and including a well-documented and easy-to-use comparison of model results
We have leading expertise in developing and validating QSAR models
We apply our machine learning expertise to the development of models in SaferSkin™ applications including customised versions for customers
Our AI team has competency in extracting targeted knowledge from information collections (documents, abstracts etc.) and organising it as structured information e.g., available to applications from a customised EdelweissData™ instance
Data Management
Our EdelweissData™ approach to data management organises all data within our system using best data practices and standards
All metadata and data is harmonised and aims for completeness and integrity
Data processing workflows are organised as reproducible in silico protocols with instances stored within the system for future reference
All in silico and in vitro protocols are fully described and stored in the system
Secure customer data management solutions can be provided through premium customer accounts on a secure cloud